Related Experiment Video

Updated: Mar 17, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.6K

Receptor for activated protein kinase C 1 suppresses gastric tumor progression through nuclear factor-kB pathway

X Yong-Zheng1, M Wan-Li1, M Ji-Ming1

  • 1Department of General Surgery, Huaihe Hospital of Henan University, Kaifeng 475000, Henan Province, PR China.

Indian Journal of Cancer
|July 26, 2016
PubMed
Abstract

Insights

Receptor for activated protein kinase C 1 (RACK1) suppresses gastric cancer progression by inhibiting nuclear factor-kB (NF-kB) signaling. Lower RACK1 levels in tumors correlate with increased cancer cell viability and NF-kB activity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Nuclear factor-kB (NF-kB) signaling is vital for the survival and proliferation of various cancers, including gastric cancer (GC).
  • Receptor for activated protein kinase C 1 (RACK1) is implicated in tumor development, but its precise role and mechanism in GC remain unclear.

Purpose of the Study:

  • To investigate the role of RACK1 in gastric cancer progression.
  • To elucidate the underlying mechanism involving NF-kB signaling.

Main Methods:

  • Analysis of RACK1 expression in human GC tissues using real-time PCR and Western blot.
  • Assessment of GC cell viability following RACK1 knockdown or overexpression in vitro.
  • Investigation of NF-kB signaling activity via luciferase reporter assays and real-time PCR.

Main Results:

  • RACK1 expression was significantly reduced in GC tissues compared to normal tissues.
  • RACK1 knockdown increased GC cell viability, while RACK1 overexpression suppressed tumor cell growth.
  • Inhibition of RACK1 led to enhanced NF-kB signaling, indicating RACK1 negatively regulates this pro-oncogenic pathway.

Conclusions:

  • RACK1 acts as a tumor suppressor in gastric cancer.
  • RACK1 suppresses gastric tumor progression by negatively regulating the NF-kB signaling pathway.

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.3K
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.5K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K